Graphic accompanying Pedersen's POV, a weekly op-ed column by MD+DI Senior Editor Amanda Pedersen, for the medtech industry.

About a year ago, renal denervation procedures won a huge victory after finally being greenlit by FDA. Now two of the frontrunners in the space have received reimbursement.

Startups and emerging medtechs are the lifeblood of medical device innovation. And yet, not enough people are talking about how these innovators are facing unprecedented challenges that have already ...

Understanding the full range of technological options in intervention catheter composite design is essential to meet the increasingly demanding requirements of catheter-based devices and delivery ...

A camera-carrying pill may soon be available as a painless alternative to invasive gastrointestinal endoscopy. The disposable capsule, which will be marketed by Given Imaging Ltd. (Yokneam, Israel), ...

The Omnigraft(TM) Dermal Regeneration Matrix from Integra LifeSciences is used to encourage the growth of skin tissue. According to the company, the product consists of a silicone layer used to shield ...

In December 2014, OtisMed Corporation agreed to pay more than $80 million after acknowledging that the company and its ex-CEO knowingly sold surgical cutting guides for knee replacements even though ...

Examining the evolving dynamics between EU and FDA regulations for medical devices. The webinar will address the historical practice of obtaining a CE Mark in Europe first, contrasting it with the ...

AtriCure is the latest player to throw its hat into pulsed-field ablation. The Mason, OH-based company revealed plans during an earnings call earlier this week. Michael Carrel, president and CEO, ...

A supplier of PVD coatings and technology to the medical device industry offers coating equipment for the deposition of biocompatible coatings. Coatings are deposited using various processes, ...